A study to evaluate the amount of drug that becomes available in the blood circulation when Savolitinib is administered alone and in combination with Itraconazole

Trial Identifier: D5084C00002
Sponsor: AstraZeneca
Collaborator:
Parexel
NCTID:: NCT04121910
Start Date: November 2019
Primary Completion Date: January 2020
Study Completion Date: January 2020
Condition: Cancer - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English version

Trial Locations

Country Location
United States of America, CA Glendale, CA, United States of America, 91206